Skip to main content

The use of in situ hybridization histochemistry for the study of neuropeptide gene expression in the human brain.

Mengod G, Charli JL, Palacios JM

Publication: Cell Mol Neurobiol (1990) • Vol 10 • Page 113-26PMID: 2334944View on PubMed

Purpose

The purpose of this paper was to examine the effect of postmortem interval (PMI), patient age, gender and Huntington's or Parkinson's disease on the levels of neuropeptide transcripts by in situ hybridization (ISH) and northern blot.

Conclusion

No significant effects of patient age, gender or PMI on the optical density of the ISH signal from preproenkephalin A, somatostatin or neuropeptide Y was observed in the three regions of striatum. The authors conclude that neuropeptide transcript levels may be examined by ISH or northern blot in postmortem tissue even after a PMI of 15 h and while brain region and disease specific differences occur there was no effect of gender or age.

Studies (1)

Purpose

The purpose of this study was to examine the effect of PMI (5.5-15 h), patient age (42-82 y), gender and Huntington's or Parkinson's disease on the levels of neuropeptide transcripts by ISH and northern blot. Specimens from 12 control and 6 Huntington's disease patients were used for analysis.

Summary of Findings

No significant effects of patient age, gender or PMI on the optical density of the ISH signal from preproenkephalin A, somatostatin or neuropeptide Y was observed in the three regions of striatum. Striatum allowed for observation of preproenkephalin A, somatostatin, neuropeptide Y, but not cholecystokinin, arginine-vasopressin and oxytocin. In the hypothalamus, preproenkephalin A, somatostatin, oxytocin and arginine- vasopressin were observed. Huntington's and Parkinson's disease resulted in decreased preproenkephalin A, but not somatostatin or neuropeptide Y. The authors conclude that neuropeptide transcript levels may be examined by ISH or northern blot in postmortem tissue even after a PMI of 15 h and while brain region and disease specific differences occur there was no effect of gender or age.

  • Biospecimens

    TissueBrain
  • Preservation Types

    Frozen
  • Diagnoses

    Cardiovascular Disease
    Huntington's Disease
    Parkinson's Disease
    Autopsy
  • Platforms

    RNAIn situ hybridization
    RNANorthern blot
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Huntington's disease
    No neuropsychiatric disorder
    Parkinson's disease
    PreaquisitionPatient age
    42 y
    62 y
    77 y
    82 y
    PreaquisitionPatient gender
    Female
    Male
    PreaquisitionPostmortem interval
    14.5 h
    15 h
    5.5 h
    6.5 h
    8.5 h
    Biospecimen AcquisitionBiospecimen location
    Hypothalamus
    Striatum-accumbens
    Striatum-caudate
    Striatum-putamen
    In situ hybridization SpecificTargeted nucleic acid
    Neuropeptide Y
    Preproenkephalin A
    Somatostatin